| 摘要 |
A system and method for comparing pharmaceutical prices and mediation utilization that provides separate databases containing (i) client pharmaceutical wholesaler and non-wholesaler purchase data, (ii) pharmaceutical compendia information, (iii) client pharmaceutical contract information, (iv) client organizational profile information, and (v) client patient volume and acuity data; and a processor in communication with the databases that (i) uploads the data and information from the databases into an input module that standardizes, validates and merges the data and information, (ii) processes the data and information from the input module by performing pricing and utilization analyses on the information and generating savings opportunities information, and (iii) formats the savings opportunities information and generates and pricing and utilization reports. A database interface for customized reporting and research analytics is also provided. |
| 主权项 |
1. A method for comparing pharmaceutical prices and mediation utilization, the method comprising the steps of:
providing a first database containing client pharmaceutical wholesaler and non-wholesaler purchase data; providing a second database containing pharmaceutical compendia information; providing a third database containing client pharmaceutical contract information; providing a fourth database containing client organizational profile information; providing a fifth database containing client patient volume and acuity data; and providing a processor in communication with the first, second, third, fourth, and fifth databases to execute the following steps of the method:
a. uploading the data and information from the databases into an input module that comprises the steps of (i) standardization of the data and information, (ii) performing a quality and verification check on the standardized data and information, (iii) merging the verified data and information with a standard pharmaceutical compendium in order to establish drug data elements and other product attributes, (iv) identifying an National Drug Code identifier from the drug compendia or assigning an internal item number for purchase data, (v) reviewing contract language for rebates, discounts and qualifying conditions, (v) merging aggregate client data from the first, third, fourth and fifth databases and aggregate compendia information from the second database into a standardized format; (vi) categorizing price file information, (vii) validating and performing a quality check on the price file information, and (viii) generating information resulting from these process steps;b. processing the information generated from the input module in a processing module that (i) performs pricing and utilization analyses on the information, (ii) integrates the analyses to identify and quantify savings opportunities, and (iii) generating savings opportunities information;c. outputting the savings opportunities information generated from the processing module to an output model that formats the savings opportunities information;d. outputting the information formatted by the output module to a pricing module and a utilization module; ande. generating at least one report from the pricing and utilization modules, with the report selected from the group consisting of a price comparison report, a price parity report, a purchase opportunity report, a utilization comparison report, a longitudinal tracking report, and a therapeutic grouping report. |
